Novo Nordisk's oral Wegovy (semaglutide) has received regulatory approval in the UK, making it the third country after the US and UAE to authorize the pill for weight management. The approval opens a new channel for obesity treatment among patients who avoid injections, and signals expanding market access for aesthetic and metabolic health distributors.
Regulatory milestone
The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved the oral formulation for adults with a BMI of 30 or higher, or those with a BMI of 27-30 who have at least one weight-related comorbidity. This clearance allows sales to private patients and through telehealth platforms, with Novo Nordisk expecting a launch within weeks.
Pricing and channel dynamics
Telehealth provider Voy has set the initial price for the 6-month launch period at £79 (about $105) per month, £10 higher than the initial monthly cost of injectable Wegovy. However, Voy's highest-dose pill is priced at £249 per month, lower than the equivalent injectable dose. Voy's Chief Medical Officer Eairim Choudhry noted that pricing may adjust as market conditions clarify.
Market impact and patient base
Novo Nordisk's oral Wegovy has already surpassed 3 million prescriptions in the US since its January launch, marking the best launch in obesity treatment history. In the UK, telehealth platform Chemist4U reported over 10,000 patients on its waiting list before approval, with about three-quarters never having used injectable weight-loss drugs. Novo Nordisk estimates the UK has approximately 15 million obesity patients.
What buyers should watch
Distributors and clinic buyers should monitor UK pricing negotiations between Novo Nordisk and the government, as well as potential NHS coverage decisions. The oral formulation's lower price point at high doses compared to injectables may shift patient preference and demand patterns. The UK approval also signals potential regulatory momentum in other European markets, which could affect supply-chain planning for aesthetic and weight-management clinics.
Source: Read the original report | Published: June 12, 2025